alexa Beta cell imaging - a key tool in optimized diabetes prevention and treatment.


Journal of Clinical & Medical Genomics

Author(s): Gotthardt M, Eizirik DL, Cnop M, Brom M

Abstract Share this page

Abstract The prevalence of diabetes is 382 million worldwide, and is expected to rise to 592 million in 2035 (; 2.5-15\% of national annual healthcare budgets are related to diabetes care, potentially increasing to 40\% in high-prevalence countries. Beta cell dysfunction and death are central events in diabetes pathogenesis, but the natural history of beta cell loss remains unknown. Clinical imaging of beta cells will play a pivotal role in developing strategies for optimized diabetes prevention and treatment. Copyright © 2014 Elsevier Ltd. All rights reserved. This article was published in Trends Endocrinol Metab and referenced in Journal of Clinical & Medical Genomics

Relevant Expert PPTs

Relevant Speaker PPTs

Recommended Conferences

  • 3rd World Congress on Human Genetics
    August 14-15, 2017 Edinburgh, Scotland
  • International Conference on Clinical and Medical Genetics
    September 21-22, 2017 Toronto, Canada
  • International Conference on Genetic Counseling and Genomic Medicine
    February 12-13, 2018 Madrid, Spain

Relevant Topics

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version